ABACUS MEDICINE PHARMA SERVICES LTDActive

Company number 08809922Private limited companyIncorporated 2013

Key figures

£329,964+1,153.3%
Net assets 2025
-10 m-7.5 m-5 m-2.5 m02.5 m202020212022202320242025

ABACUS MEDICINE PHARMA SERVICES LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m15 m202020212022202320242025
Filed accounts2020–2025
20212022202320242025
Profit for the year-2,315,277-1,956,682-1,490,3267,711,883348,035
Cash at bank and in hand168,258490,3463,199,4534,985,2630
Total assets5,608,1984,675,5855,792,8737,407,7211,961,159
Total liabilities9,933,62310,956,20513,552,4017,439,0471,631,195
Net assets / total equity-4,325,425-6,280,620-7,759,528-31,326329,964
Average number of employees182022230
Average pay (per year)———96,865—

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ABACUS MEDICINE PHARMA SERVICES LTD

Company

ABACUS MEDICINE PHARMA SERVICES LTD is a private limited company registered with Companies House under company number 08809922. It was incorporated on 11 Dec 2013. Its status is active. The registered office is in Farnborough (GU14). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Profit for the year was £348,035. Net assets were £329,964, up 1,153.3% on the previous year. Cash at bank and in hand was £0. Total assets were £1,961,159 and total liabilities £1,631,195. The company had an average of 0 employees. Figures are available for 6 financial years (2020–2025).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 1 Jan 2027.